Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: India Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20072
20083
20095
20104
20113
20123
20132
20151
20171
20192
20202
20211
20224
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Active, not recruiting2
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals12
AstraZeneca10
Boehringer Ingelheim7
Sanofi3
GlaxoSmithKline2
Hoffmann-La Roche2
Novartis2
Eli Lilly and Company1
Novo Nordisk A/S1
Phargentis SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive43
Cardiovascular Diseases2
Diabetes Mellitus2
Asthma1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21
Dyspnea1
Lung Diseases1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.